ClinicalTrials.Veeva

Menu

Natriuretic Peptides After Left Atrial Appendage Amputation

U

University of Giessen

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Procedure: LAA amputation

Study type

Interventional

Funder types

Other

Identifiers

NCT03816410
SR-345-DP

Details and patient eligibility

About

Surgical amputation of the left atrial appendage (LAA) is an established intervention during surgical atrial fibrillation (AF) therapy. However, its effects on the endocrine function of the left atrium are unclear. This study aims to quantify the serum levels of natriuretic peptides in patients who undergo concomitant surgical AF ablation with or without LAA amputation.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indication for concomitant AF therapy during cardiac surgery with cardiopulmonary bypass

Exclusion criteria

  • Lack of informed consent

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

21 participants in 2 patient groups

LAA amputation group
Experimental group
Treatment:
Procedure: LAA amputation
No LAA amputation group
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems